Cite

HARVARD Citation

    Vanitha, S. et al. (2017). Recombinant human granulocyte macrophage colony stimulating factor (hGM-CSF): Possibility of nanoparticle-mediated delivery in cancer immunotherapy. Bioengineered. 8 (2), pp. 120-123. [Online]. 
  
Back to record